Keio University
Also known as: Department of Internal Medicine, Keio University School of Medicine | Department of Internal Medicine School of Medicine Keio University | Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine | Division of Rheumatology Department of Internal Medicine, Keio University | Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine | Emeritus Professor Keio University | Keio University | Keio University Hospital | Keio University School of Medicine | Keio University, School of Medicine | Nobuyuki Katori | School of Medicine, Keio University | Upper GI Research Center, Keio University School of Medicine
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2001Last known activity
Apr 10, 2025
Timeline
1850s
- Jan 1, 1858
Keio University— Founded
Drugs by trial phase (45 distinct, 28 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (20 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Cardiovascular Diseases
- Colitis
- Colitis, Ulcerative
- Crohn Disease
- Dwarfism, Pituitary
- Endocrine System Diseases
- Growth Disorders
- Hyperlipidemias
- Hypertension
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Myelodysplastic Syndromes
- Neoplasms
- Peptic Ulcer
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Stomach Neoplasms
- Ulcer
Recent trials (42)
- NCT06913907Sponsor investigatorPhase 4Apr 10, 2025
- NCT06913907Lead sponsorPhase 4Apr 10, 2025
- NCT05679570CollaboratorPhase 2Jul 12, 2022
- NCT04546074Lead sponsorPhase 1/Phase 2Sep 14, 2020
- NCT04546074Reponsible party - principal investigatorPhase 1/Phase 2Sep 14, 2020
- NCT04546074Overall official - principal investigatorPhase 1/Phase 2Sep 14, 2020
- NCT04699994Reponsible party - principal investigatorPhase 2Jun 25, 2020
- NCT04699994Lead sponsorPhase 2Jun 25, 2020
- NCT03505008Overall official - principal investigatorPhase 4Apr 18, 2018
- NCT03505008Lead sponsorPhase 4Apr 18, 2018
- NCT03505008Reponsible party - principal investigatorPhase 4Apr 18, 2018
- NCT02413138Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2015
- NCT02307643Study chairPhase 1Feb 1, 2015
- NCT02019797Study chairPhase 4Jan 1, 2014
- NCT02019797Lead sponsorPhase 4Jan 1, 2014
Details
- Founded
- Tokyo, JP Jan 1, 1858
- Last known activity
- Apr 10, 2025